A business in context
KNSA research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-01 | Patel Sanj K | M · Exercise / conversion | Restricted Share Unit | 6481.0 | 0.0 |
| 2026-09-01 | Patel Sanj K | M · Exercise / conversion | Restricted Share Unit | 9991.0 | 0.0 |
| 2026-09-01 | Patel Sanj K | M · Exercise / conversion | Restricted Share Unit | 6237.0 | 0.0 |
| 2026-09-01 | Patel Sanj K | M · Exercise / conversion | Restricted Share Unit | 8609.0 | 0.0 |
| 2026-09-01 | Patel Sanj K | A · Grant / award | Share Option | 120150.0 | 0.0 |
| 2026-09-01 | Patel Sanj K | A · Grant / award | Restricted Share Unit | 30050.0 | 0.0 |
| 2026-09-01 | Megna Michael R | F · Tax / exercise payment | Class A Ordinary Share | 5531.0 | 79.28 |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Class A Ordinary Share | 2362.0 | n/a |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Class A Ordinary Share | 2558.0 | n/a |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Class A Ordinary Share | 3932.0 | n/a |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Class A Ordinary Share | 2644.0 | n/a |
| 2026-09-01 | Megna Michael R | A · Grant / award | Share Option | 14600.0 | 0.0 |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Restricted Share Unit | 2644.0 | 0.0 |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Restricted Share Unit | 2558.0 | 0.0 |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Restricted Share Unit | 3932.0 | 0.0 |
| 2026-09-01 | Megna Michael R | A · Grant / award | Restricted Share Unit | 3650.0 | 0.0 |
| 2026-09-01 | Megna Michael R | M · Exercise / conversion | Restricted Share Unit | 2362.0 | 0.0 |
| 2026-08-19 | Quart Barry D | G · Gift | Class A Ordinary Share | 2600.0 | 0.0 |
| 2026-08-01 | Levy Richard S | M · Exercise / conversion | Class A Ordinary Share | 403.0 | n/a |
| 2026-08-01 | Levy Richard S | M · Exercise / conversion | Restricted Share Units | 403.0 | 0.0 |
| 2026-08-01 | Levy Richard S | A · Grant / award | Restricted Share Units | 403.0 | 0.0 |
| 2026-07-29 | Cole G Bradley | G · Gift | Class A Ordinary Share | 4500.0 | 0.0 |
| 2026-07-29 | Cole G Bradley | S · Sale | Class A Ordinary Share | 3673.0 | 81.43 |
| 2026-07-15 | Megna Michael R | A · Grant / award | Class A Ordinary Share | 279.0 | 33.5 |
| 2026-07-01 | Malkani Dhiraj H | A · Grant / award | Performance Share Option | 2119.0 | 0.0 |
| 2026-07-01 | Malkani Dhiraj H | A · Grant / award | Restricted Share Unit | 14000.0 | 0.0 |
| 2026-07-01 | Malkani Dhiraj H | A · Grant / award | Performance Share Option | 2188.0 | 0.0 |
| 2026-07-01 | Malkani Dhiraj H | A · Grant / award | Performance Share Unit | 1245.0 | 0.0 |
| 2026-07-01 | Malkani Dhiraj H | A · Grant / award | Performance Share Unit | 1307.0 | 0.0 |
| 2026-07-01 | Malkani Dhiraj H | A · Grant / award | Share Option | 82600.0 | 0.0 |
Identity & relationships
SEC issuer · 0001730430Kiniksa Pharmaceuticals International, plc
Search names and former names
- Kiniksa Pharmaceuticals, Ltd. · former SEC name · 2018-02-27 to 2024-06-28
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $423.24M | $454.60M |
| 2023-12-31 | $270.26M | $298.83M |
| 2022-12-31 | $220.18M | $253.46M |
| 2021-12-31 | $38.54M | $47.92M |